Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.13M Buy
32,161
+1,057
+3% +$124K 0.12% 167
2026
Q1
$3.5M Buy
31,104
+8,166
+36% +$943K 0.09% 193
2025
Q4
$2.41M Sell
22,938
-16,267
-41% -$1.53M 0.1% 212
2025
Q3
$3.29M Buy
39,205
+3,090
+9% +$255K 0.11% 179
2025
Q2
$2.86M Buy
36,115
+15,698
+77% +$1.25M 0.11% 173
2025
Q1
$1.83M Buy
+20,417
New +$1.91M 0.08% 218

Other funds holding MRK

VestGen Advisors's MRK Position: Q2 2026 in Review

VestGen Advisors increased its Merck (MRK) stake by 3.4% in Q2 2026, buying an estimated $124K and bringing the position to 32,161 shares worth $4.13M. The position accounts for 0.12% of the portfolio, ranked #167.

VestGen Advisors first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • VestGen Advisors held 32,161 shares of Merck worth $4.13M as of Q2 2026.
  • VestGen Advisors bought 1,057 Merck shares in Q2 2026, an estimated $124K.
  • Merck made up 0.12% of VestGen Advisors's portfolio in Q2 2026, its #167 holding.
  • VestGen Advisors first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.